AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board
AIRSMIAMI BEACH, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced the appointment of Mike Doyle as the Non-Executive Chairman of its Board of Directors.
AirSculpt Technologies Announces Participation in Sidoti Micro Cap Conference
AIRSMIAMI BEACH, Fla., Aug. 13, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ: AIRS) (“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced that the Company will participate in the Sidoti Micro Cap Conference being held virtually from August 20 to 21, 2025. Management will meet with investors throughout both days and host a presentation at 10:00am ET on Wednesday, August 20. The presentation will be webcast live at https://investors.airsculpt.com. An archive of the webcast presentation will be available for 90 days.
AirSculpt Technologies Prices Underwritten Public Offering Of 3.16M Shares; Agrees To Sell Shares At $3.80/Shr For Proceeds, Before Expenses, Of $12M
AIRS12 Health Care Stocks Moving In Monday's After-Market Session
AIRSAirSculpt Technologies Announces Launch Of Underwritten Public Offering Of 3.16M Shares
AIRS12 Health Care Stocks Moving In Monday's Intraday Session
AIRS12 Health Care Stocks Moving In Friday's Pre-Market Session
AIRSAirSculpt Technologies Sees FY2025 Sales $160M-$170M vs $164.05M Est, Adjusted EBITDA Of Approximately $16M-$18M
AIRSAirSculpt Technologies Q1 2025 Adj. EPS $(0.02) Beats $(0.03) Estimate, Sales $39.37M Beat $39.25M Estimate
AIRSUncovering Potential: AirSculpt Technologies's Earnings Preview
AIRSAirSculpt Technologies Files For Mixed Shelf Of Up To $100M
AIRSWhat's Going On With Body Contouring Company AirSculpt Technologies Stock Today?
AIRSAirSculpt Technologies (AIRS) stock rises 5.44% despite missing earnings and sales estimates, as CEO expresses confidence in future growth plans.
Airsculpt Technologies Expect The Reduction In Marketing Activity At The End Of 2024 To Pressure Q1 Performance
AIRSAirSculpt Technologies Q4 2024 Adj. EPS $(0.08) Misses $(0.04) Estimate, Sales $39.178M Miss $43.386M Estimate
AIRSEarnings Scheduled For March 14, 2025
AIRSFuzzyPanda Posts On X Ozempic has sucked all the EBITDA out of $AIRS. Mgmt just guided to $AIRS just tripped their debt covenants. Needed to guide to EBITDA >$26.5m by our est's. Remediation for tripping debt covenants = all Airsculpt's debt is due immed
AIRS12 Health Care Stocks Moving In Monday's Pre-Market Session
AIRSAirSculpt Technologies Expects 2024 Revenues Of Approximately $180M Compared To Previous Guidance Of $183M-$189M And Consensus Of $185.601M, With Adjusted EBITDA Of ~$20.5M Compared To Prior Guidance Of $23M-$28M
AIRS